Press Releases

Sep 03, 2020
BOSTON --(BUSINESS WIRE)--Sep. 3, 2020-- Karuna Therapeutics, Inc. (NASDAQ:KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabling and potentially fatal neuropsychiatric disorders, today
Aug 13, 2020
BOSTON --(BUSINESS WIRE)--Aug. 13, 2020-- Karuna Therapeutics, Inc. (NASDAQ: KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabling and potentially fatal neuropsychiatric disorders,
Jul 30, 2020
BOSTON --(BUSINESS WIRE)--Jul. 30, 2020-- Karuna Therapeutics, Inc. (NASDAQ: KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabling and potentially fatal neuropsychiatric disorders and
Displaying 1 - 10 of 18
Top